TBPH·G8807B106·US·equity·Healthcare - Biotechnology-Activist
TBPH (THERAVANCE BIOPHARMA INC) is held by 103 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($69.7M), STATE STREET CORP ($21.1M), TWO SIGMA INVESTMENTS, LP ($20.4M). Net institutional sentiment: Mixed.
See how TBPH's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer